Ranolazine Versus Placebo Effects on Exercise Tolerance in Patients With Heart Disease and Peripheral Arterial Disease
|ClinicalTrials.gov Identifier: NCT00657514|
Recruitment Status : Withdrawn (Insufficient enrollment)
First Posted : April 14, 2008
Last Update Posted : August 15, 2014
Colorado Prevention Center
Information provided by (Responsible Party):
Mark Nehler, MD, Colorado Prevention Center
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
|Recruitment Status :||Withdrawn|
|Actual Primary Completion Date :||June 2009|
|Actual Study Completion Date :||June 2009|
Bauer TA, Regensteiner JG, Brass EP, Hiatt WR. Oxygen uptake kinetics during exercise are slowed in patients with peripheral arterial disease. J Appl Physiol (1985). 1999 Aug;87(2):809-16.
Barstow TJ, Lamarra N, Whipp BJ. Modulation of muscle and pulmonary O2 uptakes by circulatory dynamics during exercise. J Appl Physiol (1985). 1990 Mar;68(3):979-89.